77 related articles for article (PubMed ID: 412076)
1. [The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)].
Lewis MG; Phillips TM; Rowden G; Hammer C
MMW Munch Med Wochenschr; 1977 Oct; 119(43):1393-6. PubMed ID: 412076
[TBL] [Abstract][Full Text] [Related]
2. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
3. Immune responses in patients with T-cell lymphoma treated with an anti-idiotype antibody mimicking a highly restricted T-cell antigen.
Foon KA; Oseroff AR; Vaickus L; Greenberg SJ; Russell D; Bernstein Z; Pincus S; Köhler H; Seon BK; Tahaoglu E
Clin Cancer Res; 1995 Nov; 1(11):1285-94. PubMed ID: 9815923
[TBL] [Abstract][Full Text] [Related]
4. Immunodeficiency and cancer: mechanisms involved.
Cottier H; Hess MW; Wälti ER
Schweiz Med Wochenschr; 1986 Aug; 116(34):1119-26. PubMed ID: 3532311
[TBL] [Abstract][Full Text] [Related]
5. Recurrent and metastatic malignant disease: immunological considerations.
Carter RL
Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
[No Abstract] [Full Text] [Related]
6. Appraisal of anti-idiotypic antibodies in the treatment of solid tumors in humans.
Euhus DM; Wong JH
Surg Gynecol Obstet; 1992 Jul; 175(1):89-96. PubMed ID: 1621207
[TBL] [Abstract][Full Text] [Related]
7. [Why does a tumor grow?].
Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
[No Abstract] [Full Text] [Related]
8. Beneficial and detrimental effects of humoral immunity in malignancy.
Lewis MG; Philips TM; Rowden G
Pathobiol Annu; 1978; 8():217-39. PubMed ID: 364374
[No Abstract] [Full Text] [Related]
9. The role of circulating antibody in the control of metastases.
Lewis MG
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
[No Abstract] [Full Text] [Related]
10. Dissemination of cancer: the need for stimulation of the immune process during the immunosuppression produced by major operations.
Cole WH
South Med J; 1982 Dec; 75(12):1479-86. PubMed ID: 7146986
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of advanced ovarian carcinomas by activation of the idiotypic network.
Wagner UA; Oehr PF; Reinsberg J; Schmidt SC; Schlebusch HW; Schultes B; Werner A; Prietl G; Krebs D
Biotechnol Ther; 1992; 3(1-2):81-9. PubMed ID: 1305894
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal anti-idiotype antibodies in immunotherapy of ovarian carcinoma (MAb ACA125) and breast carcinoma (MAb ACA14C5)].
Wagner U; Köhler S; Prietl G; Giffels P; Schmidt-Nicolai S; Schlebusch H; Grünn U; Bender H; Biersack HJ; De Potter C; Krebs D; Wallwiener D
Zentralbl Gynakol; 1999; 121(4):190-5. PubMed ID: 10355096
[TBL] [Abstract][Full Text] [Related]
13. Immune cells as mediators of solid tumor metastasis.
DeNardo DG; Johansson M; Coussens LM
Cancer Metastasis Rev; 2008 Mar; 27(1):11-8. PubMed ID: 18066650
[TBL] [Abstract][Full Text] [Related]
14. Clinical and immune responses in advanced colorectal cancer patients treated with anti-idiotype monoclonal antibody vaccine that mimics the carcinoembryonic antigen.
Foon KA; John WJ; Chakraborty M; Sherratt A; Garrison J; Flett M; Bhattacharya-Chatterjee M
Clin Cancer Res; 1997 Aug; 3(8):1267-76. PubMed ID: 9815809
[TBL] [Abstract][Full Text] [Related]
15. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
[TBL] [Abstract][Full Text] [Related]
16. Natural IgM antibodies and immunosurveillance mechanisms against epithelial cancer cells in humans.
Brändlein S; Pohle T; Ruoff N; Wozniak E; Müller-Hermelink HK; Vollmers HP
Cancer Res; 2003 Nov; 63(22):7995-8005. PubMed ID: 14633732
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 fused to an anti-idiotype antibody in a vaccine increases the specific humoral immune response against CA125+ (MUC-16) ovarian cancer.
Reinartz S; Hombach A; Köhler S; Schlebusch H; Wallwiener D; Abken H; Wagner U
Cancer Res; 2003 Jun; 63(12):3234-40. PubMed ID: 12810653
[TBL] [Abstract][Full Text] [Related]
18. Cell-mediated immune mechanisms of tumor cell destruction.
Perlmann P; O'Toole C; Unsgaard B
Fed Proc; 1973 Feb; 32(2):153-5. PubMed ID: 4540104
[No Abstract] [Full Text] [Related]
19. [Origin of malignant tumors of the upper respiratory and digestive tracts and the ear (from a clinicians-point of view). 2. Pathogenesis of metastases (author's transl)].
Leicher H
Laryngol Rhinol Otol (Stuttg); 1978 Aug; 57(8):751-68. PubMed ID: 682795
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal anti-idiotype antibody bearing the internal image of nasopharyngeal carcinoma associated antigen.
Li G; Hu J; Zhou G; Zhu J; Sun Q
Chin Med J (Engl); 2001 Sep; 114(9):962-6. PubMed ID: 11780392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
